Desk› Healthcare› Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
Filing rhythm · 30 trading days
30 filings · 11 material · busiest 2026-08-11
What it files
Filings
30 in the window
-
25 August 2026
-
24 August 2026
GeneralDisclosure Under SEBI (Prohibition Of Insider Trading) Regulations, 2015
Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015
Company Update / General View filing →
-
21 August 2026
Press ReleasePress Release / Media Release
Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity.
Company Update / Press Release / Media Release View filing →
-
21 August 2026
-
18 August 2026
Concall TranscriptEarnings Call Transcript
Transcript of the post results earnings call held on August 11, 2026
Company Update / Earnings Call Transcript View filing →
-
17 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
The management of the Company will meet the investors in Singapore and Hong Kong between August 24, 2026, to August 26, 2026, in the form of a Non-Deal Roadshow (NDR).
Company Update / Analyst / Investor Meet View filing →
-
12 August 2026
Newspaper PublicationNewspaper Publication
Newspaper cutting with regard to publication of unaudited financial results for the quarter ended on June 30, 2026, in Financial Express on August 12, 2026.
Company Update / Newspaper Publication View filing →
-
12 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Update on Investor Conference
Company Update / Analyst / Investor Meet View filing →
-
11 August 2026
ResultsUnaudited Financial Results For The Quarter Ended On June 30, 2026
Unaudited financial results for the quarter ended on June 30, 2026
Result / Financial Results View filing →
-
11 August 2026
Board OutcomeBoard Meeting Outcome for Unaudited Financial Results For The Quarter Ended On June 30, 2026
Unaudited financial results for the quarter ended on June 30, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
11 August 2026
Investor PresentationInvestor Presentation
Investor Presentation
Company Update / Investor Presentation View filing →
-
11 August 2026
Press ReleasePress Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
11 August 2026
Press ReleasePress Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
11 August 2026
GeneralReporting Of Violation Of Code Of Conduct Under SEBI (Prohibition Of Insider Trading) Regulations, 2015
Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015
Company Update / General View filing →
-
11 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Audio Link of the Investor Call held on August 11 2026
Company Update / Analyst / Investor Meet View filing →
-
11 August 2026
AGM / EGMShareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM
AGM/EGM / AGM View filing →
-
11 August 2026
AGM / EGMShareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's report
AGM/EGM / AGM View filing →
-
11 August 2026
Change in DirectorateChange in Directorate
Change in Directors
Company Update / Change in Directorate View filing →
-
11 August 2026
AGM / EGMShareholder Meeting / Postal Ballot-Outcome of AGM
Regulation 44(3) disclosure of AGM 2026
AGM/EGM / AGM View filing →
-
10 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
The Company is going to participate in Motilal Oswal 22nd Annual Global Investor Conference, 2026 on August 18, 2026.
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026
Press ReleasePress Release / Media Release
Zydus launches REVAHALE, India's first once-daily nebulised LAMA for COPD.
Company Update / Press Release / Media Release View filing →
-
4 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Investor Conference
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Investor Conference
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026
Newspaper PublicationNewspaper Publication
Newspaper publication of notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati editions, both on August 4, 2026.
Company Update / Newspaper Publication View filing →
-
4 August 2026
Press ReleasePress Release / Media Release
Zydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-Days CGT exclusivity.
Company Update / Press Release / Media Release View filing →
-
30 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Q1 FY27 post results earning call details
Company Update / Analyst / Investor Meet View filing →
-
29 July 2026
GeneralReceipt Of Order From The Office Of The Superintendent Of Stamps, Gandhinagar, Gujarat
Receipt of order from the Office of the Superintendent of Stamps, Gandhinagar, Gujarat.
Company Update / General View filing →
-
23 July 2026
Press ReleasePress Release / Media Release
Zydus receives approval for Phase III trial of Desidustat in patients with Sickle Cell Disease, to be conducted in collaboration with ICMR.
Company Update / Press Release / Media Release View filing →
-
20 July 2026
Board MeetingBoard Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On June 30, 2026.
Zydus Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results ....
Board Meeting / Board Meeting View filing →
-
15 July 2026
GeneralReply To The Clarification Sought From The Company
Reply to the clarification sought from the company
Company Update / General View filing →